Autoimmune Diseases

Table of Contents: 2012

  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 160830
  • - Review Article

Theranostic Implications of Nanotechnology in Multiple Sclerosis: A Future Perspective

Ajay Vikram Singh | Manish Khare | ... | Paolo Zamboni
  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 957802
  • - Research Article

Inflammatory Demyelinating Central Nervous System Diseases in Childhood: Clinical and Paraclinical Profiles in 133 Patients

Derya Kaya | Egemen İdiman | Serkan Özakbaş
  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 296214
  • - Research Article

Autoantibodies in Senear-Usher Syndrome: Cross-Reactivity or Multiple Autoimmunity?

María Elena Pérez-Pérez | Esperanza Avalos-Díaz | Rafael Herrera-Esparza
  • Autoimmune Diseases -
  • Special Issue
  • - Volume 2012
  • - Article ID 617213
  • - Review Article

The Immunosuppressive Activity of Heat Shock Protein 70

Pawel Stocki | Anne M. Dickinson
  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 357101
  • - Review Article

Anti-Integrin Therapy for Multiple Sclerosis

Eiji Kawamoto | Susumu Nakahashi | ... | Motomu Shimaoka
  • Autoimmune Diseases -
  • Special Issue
  • - Volume 2012
  • - Article ID 836519
  • - Review Article

Impact of Exercise and Metabolic Disorders on Heat Shock Proteins and Vascular Inflammation

Earl G. Noble | Garry X. Shen
  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 312817
  • - Review Article

Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview

Hind I. Fallatah | Hisham O. Akbar
  • Autoimmune Diseases -
  • Special Issue
  • - Volume 2012
  • - Article ID 502813
  • - Review Article

Heat Shock Proteins: Pathogenic Role in Atherosclerosis and Potential Therapeutic Implications

Arman Kilic | Kaushik Mandal
  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 841085
  • - Research Article

Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries

L. Skovgaard | P. H. Nicolajsen | ... | D. W. Meyrowitsch
  • Autoimmune Diseases -
  • Special Issue
  • - Volume 2012
  • - Article ID 683212
  • - Editorial

Neurologic Manifestations of Autoimmune Diseases

Simone Appenzeller | Yehuda Shoenfeld | Jozélio Freire de Carvalho
  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 565039
  • - Clinical Study

Multicenter Retrospective Analysis of the Effectiveness and Safety of Rituximab in Korean Patients with Refractory Systemic Lupus Erythematosus

So-Young Bang | Chang Keun Lee | ... | Hye-Soon Lee
  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 784364
  • - Review Article

Cost-Effectiveness of Multiple Sclerosis Disease-Modifying Therapies: A Systematic Review of the Literature

David Yamamoto | Jonathan D. Campbell
  • Autoimmune Diseases -
  • Special Issue
  • - Volume 2012
  • - Article ID 815753
  • - Editorial

Systemic Lupus Erythematosus

Hiroshi Okamoto | Ricard Cervera | ... | Taku Yoshio
  • Autoimmune Diseases -
  • Special Issue
  • - Volume 2012
  • - Article ID 814048
  • - Research Article

A Novel Method for Real-Time, Continuous, Fluorescence-Based Analysis of Anti-DNA Abzyme Activity in Systemic Lupus

Michelle F. Cavallo | Anna M. Kats | ... | Mirjana Pavlovic
  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 403915
  • - Research Article

A Comparison of Epitope Repertoires Associated with Myasthenia Gravis in Humans and Nonhuman Hosts

Kerrie Vaughan | Yohan Kim | Alessandro Sette
Autoimmune Diseases
 Journal metrics
See full report
Acceptance rate10%
Submission to final decision84 days
Acceptance to publication36 days
CiteScore4.600
Journal Citation Indicator0.400
Impact Factor4.0
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.